| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 284,287 | 264,550 | 222,332 | 233,756 | | Cost of Revenue |
-
| (152,200) | 152,200 | 13,287 | | | Gross Profit | 284,287 | 416,750 | 70,132 | 220,469 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 258,847 | 387,596 | 45,626 | 191,099 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 25,440 | 29,154 | 24,506 | 29,370 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 33,742 | 29,154 | 24,506 | 29,370 | | Interest Expense | 2,906 | 3,045 | 2,351 | 2,770 | | Income Before Tax | 30,836 | 26,109 | 22,155 | 26,600 | | Income Tax Expense | 8,698 | 10,294 | 8,978 | 10,554 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 22,138 | 15,815 | 13,177 | 16,046 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 22,138 | 15,815 | 13,177 | 16,046 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $22,138 | $15,815 | $13,177 | $16,046 |
|
0.51% Nasdaq 
Income Statement
